Clinical observation on termination of early pregnancy of 213 cases after caesarian section with repeated use of mifepristone and misoprostol.
D000028:Abortion, Induced; D001208:Asia; D001695:Biology; D002585:Cesarean Section; D002681:China; D003906:Developing Countries; D004703:Endocrine System; D005069:Evaluation Studies as Topic; D005193:Family Planning Services; D005202:Asia, Eastern; D013502:General Surgery; D006727:Hormone Antagonists; D006728:Hormones; D015735:Mifepristone; D016595:Misoprostol; D013513:Obstetric Surgical Procedures; D010827:Physiology; D011453:Prostaglandins; D011465:Prostaglandins, Synthetic; D012106:Research; D018570:Risk Assessment; D013812:Therapeutics
D006727:Hormone Antagonists; D006728:Hormones; D011453:Prostaglandins; D011465:Prostaglandins, Synthetic; D016595:Misoprostol; D015735:Mifepristone
Abortion, Drug Induced; Abortion, Induced; Asia; Biology; Cesarean Section; China; Clinical Research; Developing Countries; Eastern Asia; Endocrine System; Evaluation; Family Planning; Fertility Control, Postconception; Hormone Antagonists; Hormones; Misoprostol; Obstetrical Surgery; Physiology; Prostaglandins; Prostaglandins, Synthetic; Research Methodology; Research Report; Risk Assessment; Ru-486; Surgery; Treatment